Data Governance And AI In Pharma: Overcoming Challenges In DACH Region

The evolution of AI and the introduction of the EU's AI Act place unprecedented importance on data governance within the biopharma sector. For professionals operating in or dealing with the DACH region, understanding the implications for compliance, local regulations, and overcoming potential tech aversion is paramount. This PharmaLex session, moderated by Chris Englerth and featuring James Meeney, provides critical insights.

Explore the fundamentals of data governance in the AI era, see practical pharma applications, and learn specific strategies for navigating the complex regulatory environment in Germany, Austria, and Switzerland. Stay ahead of the curve. View the on-demand session now.